Large-scale testing (Phase 3)Study completedNCT03206346
What this trial is testing
Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.
Who this might be right for
Influenza, HumanAcute Respiratory InfectionViral Infection+1 more
Valenta Pharm JSC 161